MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, QCLS has $37,231,786 in assets. $15,913,502 in debts.

Balance Sheets Overview

Current Ratio
170.60%
Debt to Asset Ratio
42.74%
Assets Breakdown
    • Technology license
    • Goodwill
    • Cash
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Contingent consideration payable...
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
Cash
6,904,185
Marketable securities
3,091,772
Prepaid expenses
1,150,291
Total current assets
11,146,248
Technology license
14,086,999
Goodwill
10,498,539
Investment in oravax medical
1,500,000
Total non-current assets
26,085,538
Total assets
37,231,786
Lease liability
0
Trade and other payables
3,180,662
Due to mymd fl shareholders
29,982
Dividends payable
89,728
License fees payable
337,130
Derivative liability
2,896,000
Total current liabilities
6,533,502
Contingent consideration payable, net of current
9,380,000
Total non-current liabilities
9,380,000
Total liabilities
15,913,502
Convertible preferred stock, value-Series FConvertible Preferred Stock
0
Convertible preferred stock discount-Series FConvertible Preferred Stock
0
Convertible preferred stock derivative-Series FConvertible Preferred Stock
0
Convertible preferred stock, value-Series FOne Convertible Preferred Stock
0
Convertible preferred stock discount-Series FOne Convertible Preferred Stock
0
Convertible preferred stock, value-Series GConvertible Preferred Stock
8,804,000
Convertible preferred stock discount-Series GConvertible Preferred Stock
6,938,000
Convertible preferred stock, value-Series HConvertible Preferred Stock
7,000,000
Convertible preferred stock discount-Series HConvertible Preferred Stock
2,729,083
Series h convertible preferred stock derivative-Series HConvertible Preferred Stock
1,837,000
Convertible preferred stock, value-Series IConvertible Preferred Stock
2,697,977
Total mezzanine equity
6,997,894
Preferred stock, value-Series IConvertible Preferred Stock
0
Preferred stock, value-Series DConvertible Preferred Stock
144,524
Common stock, par value 0.001, 1,250,000,000 shares authorized, 2,977,672 and 34,397 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
179,812
Additional paid in capital
151,558,433
Accumulated deficit
-137,562,379
Total stockholders equity
14,320,390
Total liabilities and stockholders equity
37,231,786
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment in oravaxmedical$1,500,000 Goodwill$10,498,539 Technology license$14,086,999 Prepaid expenses$1,150,291 Marketable securities$3,091,772 Cash$6,904,185 Total non-currentassets$26,085,538 Total current assets$11,146,248 Total assets$37,231,786 Total liabilities andstockholders equity$37,231,786 Total stockholdersequity$14,320,390 Total mezzanineequity$6,997,894 Total liabilities$15,913,502 Accumulated deficit-$137,562,379 Series h convertiblepreferred stock ...$1,837,000 Convertible preferred stock discount-Series HConvertible...$2,729,083 Convertible preferred stock discount-Series GConvertible...$6,938,000 Additional paid in capital$151,558,433 Convertible preferredstock, value-Series...$2,697,977 Convertible preferredstock, value-Series...$7,000,000 Total non-currentliabilities$9,380,000 Total currentliabilities$6,533,502 Common stock, par value0.001, 1,250,000,000...$179,812 Preferred stock,value-Series DConvertible...$144,524 Convertible preferredstock, value-Series...$8,804,000 Contingent considerationpayable, net of current$9,380,000 Derivative liability$2,896,000 License fees payable$337,130 Dividends payable$89,728 Due to mymd flshareholders$29,982 Trade and otherpayables$3,180,662

Q C TECHNOLOGIES, INC. (QCLS)

Q C TECHNOLOGIES, INC. (QCLS)